Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PALI | Palisade Bio, Inc.

Index- P/E- EPS (ttm)-7.23 Insider Own0.30% Shs Outstand9.20M Perf Week-6.65%
Market Cap5.40M Forward P/E- EPS next Y-0.87 Insider Trans111.11% Shs Float8.50M Perf Month-5.66%
Income-13.40M PEG- EPS next Q-0.34 Inst Own11.00% Short Float / Ratio2.04% / 0.06 Perf Quarter-66.08%
Sales0.30M P/S18.00 EPS this Y88.70% Inst Trans17.03% Short Interest0.17M Perf Half Y-66.28%
Book/sh2.46 P/B0.24 EPS next Y45.30% ROA-82.00% Target Price16.00 Perf Year-90.72%
Cash/sh1.76 P/C0.33 EPS next 5Y- ROE-98.80% 52W Range0.55 - 8.54 Perf YTD-88.85%
Dividend- P/FCF- EPS past 5Y70.50% ROI- 52W High-93.21% Beta1.74
Dividend %- Quick Ratio7.50 Sales past 5Y- Gross Margin- 52W Low5.36% ATR0.13
Employees12 Current Ratio7.50 Sales Q/Q- Oper. Margin- RSI (14)39.13 Volatility6.32% 12.30%
OptionableNo Debt/Eq0.03 EPS Q/Q90.80% Profit Margin- Rel Volume0.07 Prev Close0.59
ShortableYes LT Debt/Eq0.00 EarningsAug 11 BMO Payout- Avg Volume2.99M Price0.58
Recom2.00 SMA20-16.91% SMA50-53.68% SMA200-69.30% Volume203,988 Change-1.69%
Sep-14-23 07:13PM
Sep-11-23 04:01PM
08:35AM
Sep-07-23 08:30AM
Sep-06-23 08:45AM
08:05AM Loading…
Aug-11-23 08:05AM
Aug-09-23 08:05AM
Jul-05-23 08:45AM
Jun-22-23 08:30AM
Jun-14-23 08:45AM
Jun-01-23 08:45AM
May-24-23 08:45AM
May-17-23 08:30AM
May-12-23 08:05AM
May-11-23 09:05AM
09:00AM Loading…
Apr-06-23 09:00AM
Apr-05-23 08:35AM
Apr-04-23 08:30AM
Apr-03-23 08:30AM
Mar-23-23 08:05AM
Mar-15-23 08:30AM
Mar-01-23 09:05AM
Feb-08-23 08:35AM
Jan-11-23 01:00PM
Jan-10-23 08:35AM
Jan-09-23 08:45AM
Jan-04-23 05:15PM
Dec-30-22 08:45AM
Dec-16-22 08:05AM
Dec-07-22 08:35AM
02:44PM Loading…
Dec-01-22 02:44PM
Nov-22-22 08:35AM
Nov-18-22 08:05AM
Nov-17-22 08:30AM
Nov-15-22 11:15AM
Nov-14-22 08:45AM
Oct-11-22 09:25AM
Sep-29-22 08:35AM
Sep-23-22 04:30PM
Sep-21-22 09:23AM
Sep-15-22 08:30AM
Sep-13-22 09:05AM
Aug-17-22 08:35AM
Aug-16-22 04:05PM
Aug-15-22 09:00AM
Aug-12-22 08:30AM
Aug-01-22 08:05AM
Jul-27-22 08:05AM
Jun-29-22 08:30AM
Jun-07-22 08:30AM
May-13-22 09:00AM
May-10-22 05:00PM
May-06-22 08:30AM
May-05-22 08:30AM
May-02-22 08:35AM
Apr-29-22 08:05AM
Mar-30-22 03:47PM
Mar-24-22 08:30AM
Mar-22-22 08:30AM
Mar-18-22 08:30AM
Mar-16-22 08:00AM
Mar-14-22 09:15AM
Mar-09-22 08:30AM
Feb-18-22 08:30AM
Feb-15-22 08:30AM
Feb-08-22 08:00AM
Dec-29-21 08:30AM
Dec-08-21 08:00AM
Nov-30-21 08:00AM
Nov-23-21 08:00AM
Nov-15-21 07:00AM
Oct-22-21 08:00AM
Sep-09-21 08:30AM
Aug-24-21 08:15AM
Aug-20-21 09:25AM
Jul-29-21 08:15AM
Jul-13-21 08:00AM
Jun-15-21 08:15AM
Jun-07-21 05:06PM
May-13-21 07:00AM
May-07-21 09:07AM
May-04-21 08:00AM
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trenschel Robert J.DirectorSep 14Sale0.643001920Sep 15 05:15 PM
Finley John DavidCEO, CFO, DirectorSep 13Buy0.6615,0009,82528,394Sep 14 05:00 PM
Finley John DavidCEO, CFO, DirectorSep 11Option Exercise0.005,558015,186Sep 13 04:55 PM
Finley John DavidCEO, CFO, DirectorAug 06Option Exercise0.003,475011,057Aug 14 06:33 PM
Finley John DavidCEO, CFO, DirectorJul 03Option Exercise0.001,30907,582Jul 06 06:27 PM
Finley John DavidCEO, CFO, DirectorJun 12Option Exercise0.003,47507,323Jun 14 06:23 PM
McRae Robert CurtisChief Operating OfficerApr 03Option Exercise0.006550895Apr 05 06:52 PM
Finley John DavidCEO, CFO, DirectorApr 03Option Exercise0.001,30904,283Apr 05 06:49 PM